EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effectiveness of Radiofrequency Renal Denervation in the United States: Six-Month Primary End Point Results From the SPYRAL AFFIRM Study

David E Kandzari iD, Kazuomi Kario iD, Michael A Weber iD, Raymond R Townsend iD, Roland E Schmieder, Michael Böhm iD, Kostantinos Tsioufis iD, Robert Stoler iD, David P Lee, Frank Navetta, Barry Bertolet iD, Srinivasa Potluri und 7 weitere

Circulation: Cardiovascular Interventions · 03.11.2026

DOI: 10.1161/circinterventions.126.017422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, online erschienen am 03.11.2026. Verfasst von David E Kandzari und 18 weiteren Autor:innen. Beteiligte Einrichtung: Piedmont Heart Institute, Atlanta, GA (D.E.K.). Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Radiofrequency renal denervation (RDN) is a guideline-recommended therapy for uncontrolled hypertension. SPYRAL AFFIRM is a single-arm, postapproval study assessing the efficacy and safety of radiofrequency RDN using the Symplicity Spyral catheter. We report the 6-month primary end point results in the SPYRAL AFFIRM US population. METHODS: Enrolled patients had an office systolic/diastolic blood pressure (BP) ≥140/90 mm Hg and a home systolic BP ≥135 mm Hg. Patients with type 1 diabetes, poorly controlled type 2 diabetes (HbA1c >8.0%), or an estimated glomerular filtration rate

Schlagwörter

Stichwörter der Autor:innen

blood pressurehypertensionrenal denervation

Autor:innen und Institutionen

  • Piedmont Heart Institute, Atlanta, GA (D.E.K.).
  • Department of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.).
  • SUNY Downstate College of Medicine, NY (M.A.W.).
  • Perelman School of Medicine, University of Pennsylvania, Philadelphia (R.R.T., D.L.C.).
  • University Hospital Erlangen, Germany (R.E.S.).
  • HOMICAREM (HOMburg Institute for CArdioREnalMetabolic Medicine), Saarland University, Germany (M.B.).

ORCID-Profile: David E Kandzari, Kazuomi Kario, Michael A Weber, Raymond R Townsend, Michael Böhm, Kostantinos Tsioufis, Robert Stoler, Barry Bertolet, Debbie L Cohen, Te-Hsin Lung, Felix Mahfoud

Zitieren

APA

Kandzari, D. E., Kario, K., Weber, M. A., Townsend, R. R., Schmieder, R. E., Böhm, M., Tsioufis, K., Stoler, R., Lee, D. P., Navetta, F., Bertolet, B., Potluri, S., David, S., Cohen, D. L., Lung, T. H., Anderson, K., Carvelli, J., Mahfoud, F., & SPYRAL AFFIRM Study Investigators (2026). Effectiveness of Radiofrequency Renal Denervation in the United States: Six-Month Primary End Point Results From the SPYRAL AFFIRM Study. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.126.017422

Vancouver

Kandzari DE, Kario K, Weber MA, Townsend RR, Schmieder RE, Böhm M, et al. Effectiveness of Radiofrequency Renal Denervation in the United States: Six-Month Primary End Point Results From the SPYRAL AFFIRM Study. Circulation: Cardiovascular Interventions. 2026. doi:10.1161/circinterventions.126.017422

BibTeX
@article{Kandzari2026,
  author = {Kandzari, David E and Kario, Kazuomi and Weber, Michael A and Townsend, Raymond R and Schmieder, Roland E and Böhm, Michael and Tsioufis, Kostantinos and Stoler, Robert and Lee, David P and Navetta, Frank and Bertolet, Barry and Potluri, Srinivasa and David, Shukri and Cohen, Debbie L and Lung, Te-Hsin and Anderson, Kelsey and Carvelli, Julie and Mahfoud, Felix and SPYRAL AFFIRM Study Investigators, SPYRAL AFFIRM Study Investigators},
  title = {Effectiveness of Radiofrequency Renal Denervation in the United States: Six-Month Primary End Point Results From the SPYRAL AFFIRM Study},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2026},
  doi = {10.1161/circinterventions.126.017422}
}
Kostenlos starten →